Navigation Links
Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal

patients.

The Company's priority is now to identify the most expeditious path to make HyCAMP(TM) available to patients and, to that end, we will be liaising closely with the FDA and the EMEA (European Medicines Agency). Improvement in progression-free survival has been an acceptable end-point for the approval of several important cancer drugs and we believe that this study will substantially reduce the time to get HyCAMP(TM) to market."

The principal investigator of the Phase II clinical trial, Associate Professor Peter Gibbs said, "The differences in both time to treatment failure and progression-free survival are clinically meaningful and are differences that would lead to a change in clinical practice if these figures can be reproduced in a further study. The improved tumour control rates (76% in the HyCAMP(TM) arm versus 46% in the Camptosar(R) arm) are very consistent with the differences in the observed survival outcomes."

Associate Professor Tracey Brown, Alchemia's Head of Preclinical Research and inventor of the technology, added "Our preclinical data showed that HyCAMP(TM) was able to deliver a higher concentration of irinotecan (Camptosar(R)) to tumours with reduced side-effects. The targeting of drug to the tumour, coupled with the ability of HyCAMP(TM) to deliver more doses due to lower toxicity, has been successfully translated into man with a greater therapeutic benefit to patients in this Phase II trial compared with Camptosar(R)."

Dr Smith noted, "Commercially this result is very important for Alchemia. We have shown in preclinical studies that a broad range of anti-cancer drugs and antibodies can be targeted to different cancers with comparable therapeutic improvement to that seen with HyCAMP(TM). This means that the HyACT(TM) technology is capable of generating multiple product and partnering opportunities."

To view the Clinical Appendix for Alchemia Limited please go to




Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Positive Final Data from HyCAMP Phase Trial Metastatic Colorectal
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation ... its CytoSorb® blood purification technology to help fight ... in 28 countries worldwide, today announced the appointment ... MD, FACS, as its Senior Vice President of ... Dr. Di Russo is an ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014 Apnea ... expanded corporate offices in Aliso Viejo ... that due to the tremendous growth and worldwide expansion, ... Sales of patented SnoreRx, the anti snore cure have ... He said, "We are now in 23 countries ...
(Date:12/22/2014)... 2014   TRU-D SmartUVC LLC, producers of ... announced today that the General Services Administration has awarded ...   This newly formed agreement will allow ... government purchasers, including Department of Veteran Affairs and Department ... contacts purchasing solutions for the Ebola effort in ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... INDIANAPOLIS, Jan. 18, 2011 Today, patient support group Mended ... and Company, launched the Stent Hub – an online resource ... angioplasty and stenting (also known as percutaneous coronary intervention, or ... find that many ACS patients who receive a stent have ...
... Paul Pescatello has been re-elected as Chairman of the ... meeting. NEBA is a non-profit, member-driven organization ... other organizations in the six New England states with ... industry in the region, and serves as the regional ...
Cached Medicine Technology:New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure 2New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure 3Pescatello Elected to Head New England Biotech Association in 2011-12 2
(Date:12/25/2014)... New York (PRWEB) December 25, 2014 ... 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue ... reports. According to an Order issued in the U.S. ... the Court will convene an open conference on January ... and United States Courthouse in West Palm Beach, Florida. ...
(Date:12/25/2014)... The short film “Color of Honor” by ... of a true 9/11 hero, Welles Remy Crowther. It has ... 24 hours of Nuremberg International Short Film Festival and the ... Actress, screenwriter and director Luciana Lagana plays the mother ... her husband, Gregory Graham - Graham plays a ...
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... News) -- Overeating is common during the holidays, but there ... expert says. "Don,t arrive at a party hungry. It ... you,ll be attending a party, but deprivation leads to hunger, ... Northern Westchester Hospital in Mount Kisco, N.Y., said in a ... the day and even to have a snack before attending ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number ... Southern District of West Virginia, Bernstein Liebhard LLP reports. ... the Court is scheduled to convene a Joint Status ... 2015, at 10:00 a.m. Parties have been directed to ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... ... 2009 News Briefs are designed to keep you up-to-date on embargoed studies ... Society of Plastic Surgeons (ASPS) held October 23-27 in Seattle. All briefs ... advance copy of study abstracts, for media registration, or to arrange interviews ...
... NEW YORK, Oct. 6 Reportlinker.com announces that ... its catalogue. , Reportlinker Adds Novo ... http://www.reportlinker.com/p0151768/Reportlinker-Adds-Novo-Nordisk-A/S-PharmaVitae-Profile.html , Introduction , This analysis examines ... in the Rx pharmaceutical sector. The profile encompasses ...
... SHENZHEN, China, Oct. 6 /PRNewswire-Asia-FirstCall / ... or the "Company"), a,leading manufacturer and the largest exporter ... its one-for-two reverse stock,split became effective on October 6, 2009. ... trade under the old symbol "WMDG" and commenced,trading under the ...
... Oct. 6 The Blue Cross and Blue Shield Association ... Health Care Policy, today recognized six Blue Cross and Blue ... awards for their innovative and successful approaches to improving the ... its fifth year, the BlueWorks program ...
... TOWSON, Md., Oct. 6 People with primary immunodeficiency ... to connect with one another and share their experiences ... Immune Deficiency Foundation (IDF) announced today. ... chronic illnesses, caused by hereditary or genetic defects in ...
... 2009 Golden Apple Awards , CHICAGO, Oct. 6 ... and local dental societies across the nation with the 2009 ... its 21st year, recognizes outstanding achievement in dental society activities ... Awards will be presented through the end of the year ...
Cached Medicine News:Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 2Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 3Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 4Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 5Health News:Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2Health News:Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 3Health News:Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 4Health News:Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 5Health News:Winner Medical One for Two Reverse Stock Split Becomes Effective and Begins Trading Under New Symbol: WWIN 2Health News:Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives 2Health News:Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives 2Health News:Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives 3Health News:ADA Honors State and Local Dental Societies for Their Outreach Programs 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: